This article discusses Chinese development of a new vaccine against the bird flu in humans. How would the marketing and sale of this product - which is estimated to be of vital importance in the likely event that the bird flu becomes transmittable from human to human - fit in with the class discussion of international IP protections? See http://www.iht.com/articles/2008/04/03/business/drug.php